Citation:Smith MR, Fallon MA, Lee H, Finkelstein JS 2004

Citation

Smith MR, Fallon MA, Lee H, Finkelstein JS. Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. J Clin Endocrinol Metab 2004 Aug;89(8):3841-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15292315.

Critical appraisals

• Assign a critical appraisal

Cited by

1. What is the incidence of osteoporosis and reduction in bone mineral density at 2, 5 and 10 years and what is the risk of osteoporotic bone fracture due to bilateral orchidectomy (or orchidectomy), LHRH agonist or long term androgen deficiency?